You searched for {search_term_string}","query-input":"required | Page 6 of 136

The IDSA Guidelines Re-Evaluation Process

SEP

2007

...mendations will be reconsidered by the panel—so focus is critical. Panel determinations. Each contested recommendation will require a supermajority vote (75% or greater) to affirm that it is “medically/scientifically justified in light of... Read More »

TOUCHED BY LYME: Read excerpt of “Chronic,” long-awaited book by Phillips and Parish

FEB

2021

...ics are simply not effective in many cases. This, coupled with published research proving bacterial persistence despite short-term antibiotics, makes the case for longer treatments until better treatments come along. One of the... Read More »

The Lyme vaccine’s murky history and unanswered questions

AUG

2023

...peer review examining both above issues. There were several doctors and researchers who were, respectively, providing medical care for the side effects and doing research on the issues. None of them are referenced in the article, although I provided... Read More »

LYMEPOLICYWONK: IOM LIVE HEARING BLOG Part II

APR

2010

...etely ignore treatment issues B. Diagnostics, vaccines, case definitions, –input from other agencies would be useful C. Research agenda: publicly available summary Q the objective and use of the final report The ultimate... Read More »

LYMEPOLICYWONK: Chronic Lyme European PLEASE Trial—You know it’s spin when treatment “success” is called “failure”?

MAR

2016

...score at the end of the treatment period is a beneficial effect of shorter term antibiotic therapy or a nonspecific effect caused by the low level of baseline functioning, expectations associated with treatment, or placebo effects... Read More »